237 related articles for article (PubMed ID: 6145597)
21. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
22. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the existence of 'atypical' beta-adrenoceptors (beta 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro.
McLaughlin DP; MacDonald A
Br J Pharmacol; 1990 Nov; 101(3):569-74. PubMed ID: 1981688
[TBL] [Abstract][Full Text] [Related]
24. The use of functional antagonism to determine whether beta-adrenoceptor agonists must have a lower efficacy than isoprenaline to be trachea-atria selective in vitro in guinea-pigs.
O'Donnell SR; Wanstall JC
Br J Pharmacol; 1977 Jun; 60(2):255-62. PubMed ID: 18249
[TBL] [Abstract][Full Text] [Related]
25. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
26. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
[TBL] [Abstract][Full Text] [Related]
27. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
28. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
29. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
30. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.
Arch JR; Ainsworth AT; Cawthorne MA; Piercy V; Sennitt MV; Thody VE; Wilson C; Wilson S
Nature; 1984 May 10-16; 309(5964):163-5. PubMed ID: 6325935
[TBL] [Abstract][Full Text] [Related]
31. The acid metabolite of ZD7114 is a partial agonist of lipolysis mediated by the rat beta 3-adrenoceptor.
Mayers RM; Quayle SP; Thompson AJ; Grant TL; Holloway BR
Eur J Pharmacol; 1996 Jan; 295(2-3):199-205. PubMed ID: 8720584
[TBL] [Abstract][Full Text] [Related]
32. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
Carpéné C; Galitzky J; Collon P; Esclapez F; Dauzats M; Lafontan M
J Pharmacol Exp Ther; 1993 Apr; 265(1):237-47. PubMed ID: 8097243
[TBL] [Abstract][Full Text] [Related]
33. An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle.
Challiss RA; Leighton B; Wilson S; Thurlby PL; Arch JR
Biochem Pharmacol; 1988 Mar; 37(5):947-50. PubMed ID: 2830888
[TBL] [Abstract][Full Text] [Related]
34. A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs.
Takayanagi I; Koike K
Gen Pharmacol; 1985; 16(3):265-7. PubMed ID: 2862092
[TBL] [Abstract][Full Text] [Related]
35. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
Juberg EN; Minneman KP; Abel PW
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
[TBL] [Abstract][Full Text] [Related]
36. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
[TBL] [Abstract][Full Text] [Related]
37. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
38. The beta-adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3-, but also of the beta 2-subtype.
de Boer RE; Brouwer F; Zaagsma J
Br J Pharmacol; 1993 Sep; 110(1):442-6. PubMed ID: 8106109
[TBL] [Abstract][Full Text] [Related]
39. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
40. Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor.
McLaughlin DP; MacDonald A
Br J Pharmacol; 1991 Jun; 103(2):1351-6. PubMed ID: 1679358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
